Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


3M Military Earplugs Plaintiffs Can Now File Directly in Federal MDL

Veterans who blame the 3M Company’s military earplugs for their service-related hearing loss and tinnitus may now file lawsuits directly in the U.S. District Court, Northern District of Florida. All federally-filed product liability claims involving 3M Combat Arms Earplug, Version … Continue reading

Janssen Agrees to Risperdal Settlement in Key Punitive Damages Case

Janssen Pharmaceuticals has apparently agreed to settle a Risperdal lawsuit that helped open the door to punitive damages in similar cases. Risperdal Settlement Resolves Gynecomastia Claim Plaintiff Timothy Stange, a Wisconsin resident, was prescribed Risperdal as a child to control … Continue reading

Updated U.K. Guidelines for MRI Contrast Dyes Address Gadolinium Retention Concerns

The U.K. Royal College of Radiologists recently issued updated guidelines to address the risks associated with gadolinium-based MRI contrast dyes, especially recent concerns surrounding the possible retention of gadolinium in the brain and other parts of he boy. U.K. Gadolinium … Continue reading

Johnson & Johnson’s DePuy Pinnacle Hip Replacement Settlements Hit $1 Billion Mark

Johnson & Johnson has reportedly agreed to pay $1 billion to settle thousands of personal injury claims involving a metal-on-metal version of its DePuy Orthopaedics subsidiary’s Pinnacle Hip Replacement System. Pinnacle Hip Replacement Settlements: What’s Known Nearly 10,000 Depuy Pinnacle … Continue reading

FDA Warning Letter Slammed Injectafer Advertising Video’s Misleading Claims

An early Injectafer advertising campaign wasn’t well-received at the U.S. Food & Drug Administration (FDA), judging from a January 2015 Warning Letter. Injectafer and Anemia Injectafer (ferric carboxymaltose injection) is an intravenous medication that treats adults suffering from iron deficiency … Continue reading

Michigan Veteran Joins Growing Litigation Over 3M Combat Arms Earplugs

A Michigan veteran who left the service with partial hearing loss and tinnitus has joined the fast-growing litigation over the 3M Company’s Combat Arms Earplugs, Version 2. Gale Jugovich, of Portland, Michigan, was a member of the U.S. Army from … Continue reading

Jury Selection Starts Next Week for Fourth C.R. Bard IVC Filter Bellwether Trial

The fourth bellwether trial involving C.R. Bard’s retrievable IVC filters will soon get underway in the U.S. District, District of Arizona, where jury selection is scheduled to begin on Monday, May 13th. More than 7,000 Bard IVC filter lawsuits are … Continue reading

FDA Rejects Textured Breast Implant Ban, Despite Cancer Link

The U.S. Food & Drug Administration (FDA) has decided against banning textured breast implants, despite hundreds of reports linking the devices to a rare form of cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The agency apparently doesn’t believe … Continue reading

Louisiana MultiHance Lawsuit Alleges Gadolinium Toxicity After Multiple MRIs

The manufacturer of MultiHance is facing yet another lawsuit over Gadolinium Deposition Disease, an incurable and debilitating disorder that allegedly occurs after the administration of gadolinium-based MRI contrast agents. MultiHance Lawsuit Allegations According a complaint filed in the U.S. District … Continue reading

Valsartan Recall Defendants Ordered to Produce Core Discovery Materials

Core discovery has begun in the  U.S. District Court, District of New Jersey, where all product liability lawsuits related to ongoing recalls of generic valsartan medications were recently centralized for coordinated pretrial proceedings According to an Order dated April 29th, valsartan … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content